{
  "id": 32,
  "text": "A systematic literature review of relevant studies published between January 1997 and January 2017 was carried out using the MEDLINE database.This search used indexing terms as follows: 5- fluorouracil (5-FU), abdominal trachelectomy, abdominal radical trachelectomy, advanced cervical cancer, advanced cervical disease, advanced disease, advanced stage, biomarker, bleomycin, cancer antigen 125 (CA 125), cancer antigen 15-3 (CA 15-3), carboplatin, carcinoembryonic antigen (CEA), cervical cancer, cervix cancer, circulating immune complexes (CIC), cisplatin, cis-diamminedichloroplatinum, cis-platinum, clinical staging, clinically occult carcinoma, cold knife conisation (CKC), complications, computed tomography (CT), cone biopsy, cone resection, cone resection margins, conisation, cryopreservation, cytokeratin fragment 21-1 (CYFRA 21-1), destructive techniques, excisional techniques, external beam radiotherapy (EBRT), fertility, fertility outcome, fertility preservation, fertility sparing, fertility sparing management, fertility sparing surgery (FSS), Fédération Internationale de Gynecologie et d’Obstétrique (FIGO), FIGO staging system, follow-up, follow-up protocols, frozen sections, FST, gestation, high sensitivity C-reactive protein (hsCRP), HPV testing, hysterectomy, image guided adaptive brachytherapy (IGABT), image guided radiotherapy (IGRT), imaging, imaging modalities, immunosuppressive acidic protein (IAP), intensity modulated radiotherapy (IMRT), intensive care, intensive care unit, interleukin 6 (IL-6), LACC, laparoscopic staging, laparoscopy, laparotomy, large loop excision of the transformation zone (LLETZ), laser ablation, laser ablation-destruction, laser conisation, laser conisation-excision, laser destruction, length of stay, LACC, locally advanced cervical disease, locally advanced disease, locally advanced stage, loop electrosurgical excision procedure (LEEP), lymphadenectomy, lymph node (LN), LN assessment, LN dissection, LN staging, lymphovascular space involvement (LVSI), magnetic resonance imaging (MRI), metastatic disease, microinvasive cancer, microinvasive cervical cancer, mortality rate, mortality analysis, multivariate analysis, neoadjuvant chemotherapy (NACT), neonatal intensive care unit (NICU) admission, nerve-sparing radical surgery, nerve-sparing robotic radical hysterectomy, nodal involvement, obstetric outcomes, occult carcinoma, occult invasive carcinoma, occult invasive cervical cancer, oncologic outcome, ovarian preservation, ovarian transplantation, ovarian transposition (OT), oxaliplatin, paclitaxel, para-aortic lymphadenectomy, para-aortic lymph node (PALN) assessement, paraaortic lymph node dissection (PALND), pathology, pathology report, pathology report adequacy, pelvic lymph node (PLN) assessement, pelvic lymph node dissection (PLND), pelvic lymphadenectomy, perioperative care, physical examination, platinum, positron emission tomography (PET), positron emission tomography-computed tomography (PET-CT), postoperative care, postoperative complications, postoperative recurrence, pregnancy, preterm spontaneous rupture of membranes (pPROM), preoperative brachytherapy, pregnancy, pregnancy rate, pregnant patient, preoperative care, preoperative workup, prognosis, prognostic factor, quality of health care, quality of life, radical abdominal trachelectomy, radical surgery, radical trachelectomy, radical vaginal trachelectomy, recurrence, recurrent disease, reoperation, reproduction, reproductive techniques, residual disease, residual tumour, restaging, risk factors, robotic radical hysterectomy, sensitivity, sentinel lymph node (SLN), SLN procedure, sentinel node (SN), serum biomarker, serum marker, specificity, simple trachelectomy, squamous cell carcinoma antigen (SCC-Ag), staging, staging procedures, surgery, surgical management, surgical outcome, surgical outcome criteria, surgical procedures, surgical resection, surveillance, survival rate, survival analysis, tissue polypeptide antigen (TPA), TNM classification, total laparoscopic radical trachelectomy, trachelectomy, transplantation, transposition, treatment outcome, tumour-associated trypsin inhibitor (TATI), tumour necrosis factor alpha (TNF- $\\cdot \\alpha ^ { \\cdot }$ ), ultrastaging, ultrasound (US), upstaging, uterine cervix cancer, uterine transplantation, vaginal radical trachelectomy, vaginal trachelectomy, vascular space involvement, vascular endothelial growth factor (VEGF), vincristine.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A systematic literature review of relevant studies published between January 1997 and January 2017 was carried out using the MEDLINE database.This search used indexing terms as follows: 5- fluorouracil (5-FU), abdominal trachelectomy, abdominal radical trachelectomy, advanced cervical cancer, advanced cervical disease, advanced disease, advanced stage, biomarker, bleomycin, cancer antigen 125 (CA \n\n<question>: ",
  "ChatGPT_response_0": "近年来，对宫颈癌治疗和生物标志物的研究引起了广泛关注，并对宫颈癌的临床实践产生了重要影响。研究表明，针对宫颈癌的治疗方案不断演变，包括手术、放疗、化疗和靶向治疗等多种选择。生物标志物的研究也为宫颈癌的诊断、预后评估和个体化治疗提供了新的视角和方法。通过对这些研究的深入了解和运用，临床医生可以更准确地评估患者的病情，选择合适的治疗方案，提高治疗效果和生存率。因此，宫颈癌治疗和生物标志物的研究对于指导临床实践和提升患者生存质量具有重要意义。",
  "query": "在过去20年，关于宫颈癌治疗和生物标志物的研究受到了关注。你认为这些研究如何影响了宫颈癌的临床实践？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在过去20年，关于宫颈癌治疗和生物标志物的研究受到了关注。你认为这些研究如何影响了宫颈癌的临床实践？\n\n<reference text>: A systematic literature review of relevant studies published between January 1997 and January 2017 was carried out using the MEDLINE database.This search used indexing terms as follows: 5- fluorouracil (5-FU), abdominal trachelectomy, abdominal radical trachelectomy, advanced cervical cancer, advanced cervical disease, advanced disease, advanced stage, biomarker, bleomycin, cancer antigen 125 (CA 125), cancer antigen 15-3 (CA 15-3), carboplatin, carcinoembryonic antigen (CEA), cervical cancer, cervix cancer, circulating immune complexes (CIC), cisplatin, cis-diamminedichloroplatinum, cis-plati\n\n<reply>: ",
  "response": "近年来，对宫颈癌治疗和生物标志物的研究引起了广泛关注，并对宫颈癌的临床实践产生了重要影响。研究表明，针对宫颈癌的治疗方案不断演变，包括手术、放疗、化疗和靶向治疗等多种选择。生物标志物的研究也为宫颈癌的诊断、预后评估和个体化治疗提供了新的视角和方法。通过对这些研究的深入了解和运用，临床医生可以更准确地评估患者的病情，选择合适的治疗方案，提高治疗效果和生存率。因此，宫颈癌治疗和生物标志物的研究对于指导临床实践和提升患者生存质量具有重要意义。"
}